[Periocular basal cell carcinoma treatment tendencies]

Arch Soc Esp Oftalmol. 2010 Aug;85(8):261-2. doi: 10.1016/j.oftal.2010.09.008. Epub 2010 Oct 23.
[Article in Spanish]
No abstract available

Publication types

  • Editorial

MeSH terms

  • Aminolevulinic Acid / analogs & derivatives
  • Aminolevulinic Acid / therapeutic use
  • Aminoquinolines / therapeutic use*
  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Basal Cell / drug therapy*
  • Carcinoma, Basal Cell / epidemiology
  • Carcinoma, Basal Cell / surgery
  • Conjunctival Neoplasms / drug therapy*
  • Conjunctival Neoplasms / epidemiology
  • Conjunctival Neoplasms / surgery
  • Eyelid Neoplasms / drug therapy*
  • Eyelid Neoplasms / epidemiology
  • Eyelid Neoplasms / surgery
  • Humans
  • Imiquimod
  • Immunologic Factors / therapeutic use*
  • Mohs Surgery
  • Neoplasms, Radiation-Induced / drug therapy
  • Neoplasms, Radiation-Induced / epidemiology
  • Neoplasms, Radiation-Induced / surgery
  • Patient Satisfaction
  • Photochemotherapy
  • Photosensitizing Agents / therapeutic use*
  • Sunlight / adverse effects

Substances

  • Aminoquinolines
  • Antineoplastic Agents
  • Immunologic Factors
  • Photosensitizing Agents
  • methyl 5-aminolevulinate
  • Aminolevulinic Acid
  • Imiquimod